Priority Date: 04.12.12 (US 201261733260P)

NOVEL MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR KINASE DOMAIN

  • Application ID: EP13798354
  • Status: GRANT OF PATENT INTENDED

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Roche Diagnostics GmbH is specialized in C12. Roche Diagnostics GmbH is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 04.12.2012 - Priority Date (US 201261733260P)
  • 12.06.2014 - Publication A1 (WO2014086707)
  • 14.10.2015 - Publication A1 (EP2929049)

IPC Classification